Potential prevention strategies for Alzheimer disease

Alzheimer Disease and Associated Disorders

Volumn 10, Issue SUPPL. 1, 1996, Pages 6-8

  Thal, Leon J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer disease; Epidemiology; Primary prevention

Indexed keywords

AMYLOID; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; APOLIPOPROTEIN E4; ESTROGEN;

ALZHEIMER DISEASE; CLINICAL PROTOCOL; ENVIRONMENTAL FACTOR; HEALTH CARE COST; HUMAN; MORBIDITY; PRIMARY PREVENTION; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0029838429     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-199601031-00002     Document Type: Short Survey

References (6)

1. Bachman DL, Wolf PA, Linn RT, et al. Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham study. Neurology 1993;43:515-9.
2. Breitner JCS, Gau BA, Welsh KA, et al. Inverse association of antiinflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology 1994;44:227-32.
3. Ernst RL, Hay JW. The U.S. economic and social costs of Alzheimer's disease revisited. Am J Public Health 1994;84:1261-4.
4. Grundman M, Petersen RC, Morris JC, et al. ADCS Cooperative Study. Rate of dementia of the Alzheimer type (DAT) in subjects with mild cognitive impairment. Neurology 1996;46:403.
5. Hebert LE, Scherr PA, Beckett LA, et al. Age-specific incidence of Alzheimer's disease in a community population. JAMA 1995;273:1354-9.
6. Paganini-Hill, Henderson VW. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994;140:256-61.